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RAPID COMMUNICATION

Human Eosinophils Express Functional CD30 Ligand and Stimulate Proliferation of a Hodgkin's Disease Cell Line
By Antonio Pinto, Donatella Aldinucci, Annunziata Gloghini, Vittorina Zagonel, Massimo Degan, Salvatore Improta, Senka Juzbasic, Michela Todesco, Vilma Perin, Valter Gattei, Friedhelm Herrmann, Hans-Jurgen Gruss, and Antonino Carbone
The presence of a prominent tissue eosinophilia represents a typical histopathologic hallmark of Hodgkin's disease (HD).
To evaluate the putative role of eosinophils on tumor cell regulation in HD, we have analyzed these cells for the functional expression of CD30 ligand (CDSOL), a surface molecule able t o transduce CD3O-mediated proliferation signals on Hodgkin's (H) and Reed-Sternberg (RS) cells. The results demonstrate that circulating and tissue eosinophils from normal donors and patients with HD or hypereosinophilic syndrome (HES), display CD3OL mRNA and express CD3OL protein, as shown by immunostaining with a specific monoclonal antibody (M80) and with a biotinylated soluble CD30-Fc fusion protein. The surface density of CD3OL on eosinophils from HD and HES patients was remarkably higher compared with heatthy donors, probably reflecting a cytokine-mediated upregulation in these pathologic condi-
HE DIAGNOSTIC LESION of Hodgkin's disease (HD)
T is characterized by the presence of typical multinucle-
ated malignant Reed-Stemberg (RS) cells and their mononuclear Hodgkin's (H) cells variants amid a reactive cellular background mainly consisting of T and B lymphocytes, plasma cells, histiocytes, stromal cells, and eosinophils.'.'
The presence of a prominent eosinophil infiltration in HD tissues was described as early as one century Subsequent studies have shown that eosinophil infiltration may be observed in up to 89% of nodular sclerosis (NS) and mixed cellularity (MC) HD cases, while it represents a very infrequent finding in the lymphocyte predominance (LP) subtype of HD.J*6 In addition, the massive extracellular deposition of eosinophil degranulation products, including eosinophil peroxidase and eosinophil basic protein, has been detected in HD tissues even in the absence of morphologically identifiable intact eosinophil^.'.^.^ Patients with HD may also display eosinophilia in peripheral blood (PB) and bone marrow
The cause for the frequent eosinophilia in HD remains uncertain even though a partial explanation is provided by the finding that cultured H-RS cells synthesize interleukin-5 (IL-5)''-13 and granulocyte-macrophage colony-stimulating factor (GM-CSF),"-I3 which are potent stimulators of eosinophil growth, recruitment, and functional a~tivation.'"'~ Similarly, the presence of IL-5 mRNA was demonstrated by in situ hybridization in H-RS cells but also surrounding reactive T cells from a high proportion of HD cases with eosinophilia.s.",'3*'5*'6 In addition, the extensive presence of IgE deposits in H-RS and neighboring cells as well as connective tissues, may also account for the prominent eosinophil infiltration typical of most HD cases.I7
Despite the well-established eosinophilia of HD, the possible role of eosinophils in the regulation of H-RS cells growth and functional activation has not been addressed so far. On the other hand, several evidences suggest that tumor cell proliferation and expansion in HD may be regulated by a (BM). 1.3-S,9,10 tions. Accordingly, we provide evidence that cytokines regulating eosinophils proliferation and activation, ie, interleukin-5 (IL-5). IL-3, and granulocyte-macrophage colonystimulating factor (GM-CSF), are able t o enhance the cellular density of CDBOL on purified eosinophils from normal subjects. Finally, we show that native CD3OL on human eosinophils is a functionally active surface structure able t o transduce proliferative signals on CD30' target cells, including cultured H-RS cells. Our data suggest that eosinophils may not merely represent innocent bystanders, but rather act as important elements in the pathology of HD by contributing t o the deregulated network of CDSOICDBOL-mediated interactive signals between H-RS cells and surrounding reactive cells. 0 1996 b y The American Society of Hematology.
complex network of cytokine-and cell contact-dependent interactions among H-RS cells and surrounder reactive cells, accumulating in HD-involved tissues.2.".'8.'9 For instance, CD4+ T lymphocytes, are able to bind H-RS cells through specific membrane antigens by delivering direct growth a n d or anti-apoptotic signals and favoring the action of T-cellderived cytokines on the tumor cell p~pulation.~*''~'~~'*-' ' Among the panel of surface molecules typically expressed by H-RS cells, CD30 has been recently characterized as a transmembrane growth factor receptor belonging to the tumor necrosis factor (TNF)/nerve growth factor (NGF) receptor s~p e r f a m i l y .~~,~~ A cell-associated specific ligand for CD30 (CD30L), with homology to other members of the TNF-ligand superfamily, has been later identified on activated T cells and stimulated monocytes/macrophages.18*24-26 CD30L stimulates proliferation of some cultured H-RS cells use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From via a CD30-mediated intracellular signalling pathway, also causing cellular activation with enhanced cytokine secretion (eg, IL-6, TNF, LT-a) and surface antigens expression (eg, CD54, CD80, CD86).".24-27 CD30 and CD30L might therefore represent a molecular pair critically involved in the control of tumor cell growth and activation in HD.'l. 18.22-27 To clarify the pathobiologic significance of eosinophil infiltration in HD, we investigated whether circulating or tissue eosinophils from normal individuals or HD patients could express functionally active CD30L and assessed the ability of purified eosinophils to stimulate proliferation of cultured H-RS through a CD30-dependent mechanism.
MATERIALS AND METHODS
PB buffy coats were obtained from consenting healthy donors (n = IO), patients with HD (n = 5), and patients with hypereosinophilic syndrome (HES)'."' (n = 4). In addition, pleural effusions from three patients with HD were studied.20.28 To isolate eosinophils a two-step procedure was used which combines density gradient centrifugation with removal of contaminating neutrophils by negative immunomagnetic selection, as de~cribed.''~~~ Briefly, after 2.25% dextran sedimentation cells were washed and centrifuged through six isotonic (osmolality of 285 to 294 mOsm/kg) discontinuous Percoll (Pharmacia, Uppsala, Sweden) gradients, with densities ranging from 1.077 g/mL to 1.105 glmL," as measured with a pycnometer at 20°C. Interfaces at a specific gravity of 1.090, 1.095, and I . 105 g/mL were collected and depleted of contaminating neutrophils by incubation with the anti-CD16 monoclonal antibody (MoAb) CLBFcR gran 1 (Miltenyi Biotec Inc, Celbio, Milan, Italy) followed by sheep anti-mouse IgGcoated immunomagnetic beads (Dynabeads, Dynal, Norway). Eosinophil preparations (95% to 98% pure, as assessed by May-Grunwald Giemsa staining) were either fixed in 0.5% paraformaldehyde or resuspended in Iscove's modified Dulbecco medium (IMDM; GIBCO, Paisley, Scotland) supplemented with 5% fetal calf serum (FCS; GIBCO) and used for immunofluorescence studies, RNA preparation, in vitro cultures, and functional assays.
The anti-CD30L MoAb M80 (mouse IgG2b isotype) was developed and characterized as described." Indi- 
MoAbs andflow cytometry.
Research and Development Corp, Seattle, WA), and biotinylated control IgGl for 30 min at 4"C, as previously described.'"'' Cells were then washed, incubated with streptavidin-phycoerythrin (Becton D i c k " ) , and analyzed by flow cytometry.
The human lymphoma cell lines DG-75 and MN-60 expressing surface CD30L, the CD30' HD-derived cell line HDLM-2 and the CD30' anaplastic large cell lymphoma (ALCL) cell line Karpas were obtained through the German Collection of Microorganisms and Cell Cultures (Braunschweig, Germany) and used as positive controls for CD30L and CD30 in immunostaining procedures and mRNA analysis.
Immunohistochemistry. Reactive (n = 9), angioimmunoblastic lymphadenopathy (A1LD)-involved (n = 3). and HD-involved (n = 7) lymph node tissues were fixed in Bouin solution or neutral buffered formalin.
Anti-CD30L MoAb M80 was applied to deparaffinized tissue sections from all cases included in the study. Immunohistochemistry was performed with the alkaline phosphatase anti-alkaline phosphatase (APAAP) method as described.2"~2n Cytospin smears of purified eosinophil preparations were fixed in neutral buffered formalin at room temperature for 10 minutes and then immunostained with the anti-CD30L MoAb M80 by the APAAP method.2".'x~3'
RNA isolation and reverse transcriptase-polymrrclse chain reaction (RT-PCRJ. Total RNA ( I p g ) , extracted by the guanidium thiocyanate method,2",zx was reverse-transcribed by avian myeloblastosis virus (AMV) reverse transcriptase (Promega Co, Madison, WI) in a 20-pL reaction mix containing hexadeoxyribonucleotides random primers (0. PCR conditions for CD30 and CD30L were 4 minutes at 94°C followed by 35 cycles of 45 seconds at 94"C, 1.5 minutes at 68°C (45 seconds at 6 2 T , 1 minute at 72°C for CD30), and a final extension of 5 minutes at 72°C. In the case of P-actin, amplification was performed for 30 cycles according to the manufacturer's guidelines. Fifteen microliters of amplified cDNAs were run in 1.5% agarose gels, blotted onto nylon membranes (Boehringer Mannheim) and hybridized with 2 x 10' cpm/mL of fi'-end-labeled oligoprobes, specifically designed to recognize PCR products. The CD30L and CD30 probes spanned nucleotide positions 684-707 and 12 16-124 I , respectively.
Purified eositiophils (2.0 X 105/mL) were cultured for 12, 24, 48, 60, and 72 hours in IMDM supplemented with 5% FCS in the presence of increasing concentrations GM-CSF (2, IO, SO, and 100 ng/mL), IL-3 (2, 5, 10, and 50 ng/mL), IL-5 (1, 2, 5, and 10 ng/mL) or combinations of the same cytokines. All recombinant cytokines were obtained from Genzyme Co (Cambridge, MA).
The CD30' HDLM-2 and Karpas 299 cell lines were used as responsive target cells to investigate the capability of native CD30L on human eosinophils to transduce CD30-mediated growth signals.24-26 Titrations of purified eosinophils (25-50-100 X IO'lwell) were fixed in 0.5% paraformaldehyde as described,''~"' and cocultured for 72 hours with HDLM-2 or Karpas 299 cells (1 X 10' cells/ mL) in 96-well U-bottomed microplates. Similar studies were also performed by using unfixed viable eosinophils. Control experiments were performed in the presence of an excess (10 pg/well) of CD30-Fc fusion protein to specifically block CD30-CD30L interac- 
RESULTS
Expression of CD3OL on purijed and tissue eosinophils.
Eosinophils from normal donors, HES and HD patients displayed a constitutive expression of CD30L (Fig 1) . Purified cells were consistently stained either by the anti-CD30L MoAb M80 and CD30-Fc fusion protein as shown by flow cytometry (Fig 1A) . Interestingly, eosinophils from PB a n d or pleural effusions of patients with active HD or with HES showed a higher constitutive expression of surface CD30L. compared with eosinophils from normal subjects (Fig 1A) . In detail, a mean CD30L staining intensity of 2,639 5 143 MESF was recorded with the M80 MoAb on purified eosinophils from 10 normal donors, as opposed to 3,618 ? 101 and 3,694 2 85 MESF ( P = .OOl) for eosinophils from HD (n = 5) and HES (n = 4) patients, respectively. Conversely, circulating and tissue eosinophils from either normal donors or patients did not express surface CD30 (data not shown).
Fluorescence Intensity
Immunocytochemistry of cytospin preparations with MoAb M80 confirmed the expression of CD30L, with a cytoplasmic staining mainly leaning against the nuclear membrane on the majority of purified eosinophils (not shown).
Expression of CD30L mRNA was also studied by RT-PCR. As shown in Fig lB, a 689 -bp amplified cDNA product specific for CD30L was detectable in purified eosinophils from normal donors, and HD and HES patients. CD30L mRNA was also present in DG-75 cells (positive control) but not in Karpas 299 cells (negative control). Eosinophils from different sources did not display mRNA for CD30, which was conversely found in Karpas 299 cells (positive control) .
CD30L expression was also consistently detected on tissue eosinophils from 9 reactive (Fig 2A) and 10 pathologic ( Fig  2B) lymph nodes, including AILD (n = 3) and HD (n = 7) cases. Surface expression of CD30L was associated with a disperse granular staining pattern in the cytoplasm of the great majority of eosinophils (Fig 2A-B) . In several cells the cytoplasmic staining was more evident along the nuclear membrane. Anti-CD30L MoAb M80 also displayed specific reactivity with nonphagocytosing histiocytes and endothelial cells of postcapillary venules (Fig 2A) . Staining of histiocytes was homogeneous and stronger, compared with that of eosinophils and endothelial cells.
Regulation of CD3OL expression on cultured eosinophils. To evaluate the effects of cytokines involved in functional use only. activation of eosinophils for the regulation of CD30L, more than 95% pure eosinophils preparations from normal donors were cultured in the presence of increasing concentrations of IL-5, GM-CSF, and E-3. A dose-dependent upregulation of surface CD30L was observed upon exposure for 24 hours to GM-CSF and IL-5, which was maximal at concentrations of 100 ng/mL (2.0-fold of net MESF increase) and I O ng/ mL (2.2-fold of net MESF increase), respectively (Fig 3A  and B) . CD30L constitutive cellular density was enhanced by 1.2-to 1.8-fold at GM-CSF concentrations of 2 ng/mL to 50 ng/mL, and by 1.4-to 1.7-folds at E-5 concentrations of 1 ng/mL to 5 ng/mL (not shown). IL-5 and GM-CSF displayed a higher capability to enhance the surface density of CD30L on human eosinophils compared with IL-3 (1.3-fold at the peak concentration of 10 ng/mL) (Fig 3B) . Higher IL-3 concentrations (up to 50 ng/mL) did not result in further CD30L upregulation (not shown). However, the maximal increase of CD30L specific fluorescence intensity (3-to 4-fold) was obtained by the combination of optimal concentrations of GM-CSF and IL-3 (Fig 3A and B) . The addition of IL-5 to the GM-CSF plus IL-3 combination did not further increase CD30L expression (Fig 3B) . Cytokine-mediated upregulation of surface CD30L was maximal at 24 hours and sustained for up to 48 to 60 hours (data not shown). These data show that expression of CD30L is highly regulated by physiological cytokines involved in recruitment and functional activation of human eosinophils.
CD3OL expressed on eosinophils is functionally active. To examine if native CD30L expressed at the surface of eosinophils was functionally active on CD30' target cells, titrations of 0.5% paraformaldehyde-fixed purified human eosinophils (CD30L+) were cocultured with 1 X IO5 HDLM-2 or Karpas 299 cells/mL. Previous studies'426 have shown that these CD30+ cell lines are able to proliferatively respond to membrane-expressed recombinant CD30L by being either growth-stimulated (HDLM-2) or growth-inhibited (Karpas 299). Biologic responses mediated by native CD30L expressed on eosinophils were detected using the 'H-TdR incorporation assay. As shown in Fig 4, CD30L ' eosinophils induced a dose-dependent proliferation of the HD-derived cell line HDLM-2 and inhibited growth of the ALCL cell line Karpas 299. The CD30L-mediated proliferative effects of eosinophils appeared to be specific because both growth stimulatory (HDLM-2) and inhibitory (Karpas 299) effects could be blocked by the addition of an excess (10 pg/mL) of soluble CD30-Fc fusion protein (Fig 4) .
of HD.'-h.9.'n In the present study we have shown that human circulating eosinophils display CD30L mRNA and surface protein. In addition, immunohistochemical staining with the anti-CD30L MoAb M80 indicated that most of tissue eosinophils in reactive and HD-involved lymph nodes express immunodetectable CD30L in vivo. The constitutive surface density of CD30L on eosinophils from HD and HES patients was significantly higher compared with normal donors, probably reflecting a cytokine-mediated activation of eosinophils in these pathologic conditions?,'" In addition, we have shown here that the concerted action of cytokines leading to eosinophil functional activation, ie, IL-5, IL-3, and GM-CSF?'3." may concurrently upregulate CD30L at the surface of cultured normal eosinophils. Previous studies have shown a selective enhancement of IL-5, IL-3, and/or GM-CSF levels in sera and tissues of patients with primary or secondary hypereosinophilia and HD, even though cytokine serum concentrations were overall lower than those eliciting maximal CD30L upregulation on cultured normal eosinop h i~s .~, 9 .~~. i~. l~.~~-~7
However, systemic cytokine levels may not reflect concentrations that are obtained in vivo at sites relevant for biologic activity, and it has been recently suggested that local concentrations of cytokines might be much greater than expected." Therefore, it is conceivable that higher tissue concentrations of IL-5, IL-3, and GM-CSF may be actually achieved within the HD microenvironment. at the sites of contact-dependent interactions of H-RS cells with surrounding reactive cells, including eosinophils.'.' '.''. I9 To evaluate whether native CD30L on human eosinophils was functionally active, the CD30' cell lines HDML-2 (HD) and Karpas 299 (ALCL) were incubated in vitro with paraformaldehyde-fixed or viable purified eosinophils. We were able to show that CD30 engagement by CD30L-expressing eosinophils, resulted in the dose-dependent proliferation of HDLM-2 cells and in the growth inhibition of Karpas 299
L4~fi 1 GM-CSF+IL-3
Fluorescence Intensity eosinophils were able to induce proliferation of HDLM-2 cells up to 2.5-to 3-fold over basal growth at the highest eosinophil concentration (100 X 103/well), this effect being blocked by more than 70% in the presence of soluble CD30-Fc (data not shown). In addition, paraformaldehyde-fixed human eosinophils were unable to elicit any proliferative effect on the B-cell line SC-I, which lacks surface CD30 (not shown). Thus, native CD30L on human eosinophils is a functionally active surface structure able to transduce CD30-mediated growth signals. Therefore, it appears likely that eosinophils recruited and activated by H-RS-and T-cell-derived cytokines (IL-5, IL-3, GM-CSF), may in turn interact with these cells, and contribute with both membrane-bound ligands (CD30L, CD40L) and soluble cytokines (TGF-P, GM-CSF, IL-1, IL-3, IL-5, IL-6, and IL-8)" to the deregulated cellular reaction underlying tumor cell growth and survival in HD.2.."..'3,. '8 The prognostic relevance of eosinophilia in HD appears controversial.'~5~y~'o In this regard, although PB eosinophilia has been considered as a good prognostic indicator:7.@ a massive eosinophilic infiltration into HD tissues was found to be associated with a poor clinical outcome."' In addition, a more recent study specifically addressing the prognostic significance of tissue eosinophils, has shown, by a multivariate statistical approach, that an heavy tissue eosinophil infiltration represented the most important negative prognostic factor affecting disease-free survival in a series of 140 primary HD patients, treated according to a prospective protocol." Should this latter observation be confirmed by other clinical series, HD again will turn as a tumor with unique biologic properties. Usually, a prominent eosinophilic infiltration within tumor tissues rather predicts a favorable out-RS ce~~s~23-Z5.Z7.3.'
Medium
PINTO ET AL come in other malignancies including cervix, lung, gastric, and colorectal carcinomas.".'" Whether eosinophil-mediated activation of the CD30 system on either H-RS cells or other reactive cells (ie, CD4' T cells) may have a role in HD progression remains to be established. Interestingly, however, in nodular lymphocyte predominance HD, where eosinophils infiltration is a very rare o c c~r r e n c e ,~~~~~~ H-RS cells do not usually express CD30 and the disease shows a prolonged and indolent clinical course.2, 13,23,s1 Our present data suggest that eosinophils may act as important elements in the pathology of HD by contributing to the deregulated network of CD30/CD30L-mediated interactive signals between H-RS cells and surrounding reactive cells.
